


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.79%
-2.40%
-4.96%
-12.16%
-2.01%
ARDX
Ardelyx
$6.27
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Technical Indicators

MACD above signal line
ARDX Price Performance
$7.32 (-14.34%)
$5.8 (+8.10%)
$4.93 (+27.18%)
$5.13 (+22.22%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Earnings decline YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
ARDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ARDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
ARDX has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 02, 2026
Price Target Raised
Buy
TD Cowen
Jan 30, 2026
Reiterate
Buy
Jefferies
Jan 26, 2026
Upgrade
Buy
Zacks
Nov 18, 2025
Reiterate
Buy
Piper Sandler
Nov 05, 2025
Reiterate
Neutral
Piper Sandler
What is ARDX current stock price?
What are ARDX stock strengths?
What is ARDX Risk Level?
What is ARDX market cap and volume?
What is ARDX current Stock IQ?
Should I buy ARDX stock right now?
Is ARDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for ARDX?
What does a 'Strong Sell' rating mean for ARDX?
What factors influence ARDX's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
ARDX
Ardelyx
Current Price
$6.27

ARDX Price Performance
$7.32 (-14.34%)
$5.8 (+8.10%)
$4.93 (+27.18%)
$5.13 (+22.22%)
ARDX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Earnings decline YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
ARDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ARDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
ARDX has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
ARDX Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Technical Indicators

MACD above signal line
ARDX Latest Analysis
Ardelyx gains after insider purchase LPGA marketing deal.
Tue Feb 24, 2026
Ardelyxs post-earnings decline attributed to concerns over Ibsrela outlook.
Fri Feb 20, 2026
Ardelyx: Strong IBSRELA Growth But Heavy Operational Spend Clouds Profitability.
Fri Feb 20, 2026
Ardelyx Lead Drug Growth Fails To Lift Sentiment Stock Drops. ) shares are down during Friday’.s premarket session financial update for the fourth quarter of 2025.Ardelyx reported breakeven versus the consensus earnings of 1 cent. Sales reached $125.22 million beating the .The company reported that IBSRELA (tenapanor) revenue grew 73% in 2025 to $274.2 million contributing to total revenues of $407.3 million. The company recorded $86.6 million in IBSRELA revenue in the fourth quarter up 61
Fri Feb 20, 2026
Ardelyx outlines $1B IBSRELA revenue target by 2029 while advancing CIC label expansion and new pipeline.
Fri Feb 20, 2026
Ardelyx (ARDX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates. Although the revenue and EPS for Ardelyx (ARDX) give a sense of how its business performed in the quarter ended December 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Thu Feb 19, 2026
Ardelyx GAAP EPS of $0.00 misses by $0.01 revenue of $125.25M beats by $7.21M.
Thu Feb 19, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ARDX Stock trends
ARDX Stock performance
ARDX Stock analysis
ARDX investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.